Trevi Therapeutics (TRVI) Leases (2019 - 2026)
Trevi Therapeutics' quarterly Leases came in at $610000.0 in Q1 2026, down 29.48% year-on-year from $865000.0 in Q1 2025, and down 9.9% quarter-over-quarter from $677000.0 in Q4 2025.
Trevi Therapeutics has reported Leases for 8 years, with the latest figure at $610000.0 in Q1 2026.
- For the quarter ending Q1 2026, Leases fell 29.48% year-over-year to $610000.0; the trailing twelve-month figure through Mar 2026 stood at $610000.0 (down 29.48% YoY), and the FY2025 full-year result was $677000.0, down 26.01% from the prior year.
- Leases for Q1 2026 stood at $610000.0, down from $677000.0 in the prior quarter.
- The five-year high for Leases was $1.3 million in Q1 2023, with the low at $24000.0 in Q4 2022.
- Average Leases over 5 years is $640062.5, with a median of $709000.0 recorded in 2025.
- Year-over-year, Leases jumped 2145.28% in 2023 and slumped 85.41% in 2024.
- Tracing TRVI's Leases over 5 years: stood at $24000.0 in 2022, then jumped by 758.33% to $206000.0 in 2023, then surged by 344.17% to $915000.0 in 2024, then dropped by 26.01% to $677000.0 in 2025, then fell by 9.9% to $610000.0 in 2026.
- The last three Leases figures came in at $610000.0 (Q1 2026), $677000.0 (Q4 2025), and $741000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | 610,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 610,000.00 |
| Dec 31, 2025 | 677,000.00 |
| Sep 30, 2025 | 741,000.00 |
| Mar 31, 2025 | 865,000.00 |
| Dec 31, 2024 | 915,000.00 |
| Sep 30, 2024 | 973,000.00 |
| Jun 30, 2024 | 181,000.00 |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 206,000.00 |
| Sep 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 24,000.00 |
| Sep 30, 2022 | 53,000.00 |
| Jun 30, 2022 | 82,000.00 |
| Mar 31, 2022 | 107,000.00 |
| Dec 31, 2021 | 131,000.00 |
| Sep 30, 2021 | 156,000.00 |
| Jun 30, 2021 | 181,000.00 |
| Mar 31, 2021 | 204,000.00 |
| Dec 31, 2020 | 227,000.00 |
| Sep 30, 2020 | 250,000.00 |
| Jun 30, 2020 | 271,000.00 |
| Mar 31, 2020 | 292,000.00 |
| Dec 31, 2019 | 312,000.00 |
| Sep 30, 2019 | 331,000.00 |
| Jun 30, 2019 | 350,000.00 |
| Mar 31, 2019 | 368,000.00 |